Dealing with drug shortages is a standard part of the logistics for hospitals in the U.S., according to pharmacists and to Joseph Flynn of Louisville-based Norton Cancer Institute."Cisplatin and carboplatin have come up short," Flynn said."A lot of these are manufactured in other countries and they have a process of standards, or if there's issues in the process it can disrupt, especially if it is used so widely.
In the short term, Canadian pharmaceutical company Apotex has been distributing injectable medication on a temporary basis since early June. And it's up to local treatment centers to determine how to stretch out their supply for their patients in the meantime, according to Tina Claypool, the clinical pharmacy supervisor of University of Louisville Health.
One of the nation's top cancer care groups, the American Society of Clinical Oncology, is now advising doctors with low quantities to administer them to patients with a better shot at a cure, and to deny them to patients with recurrent or widely spread disease.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: bbchealth - 🏆 143. / 63 Read more »
Source: washingtonpost - 🏆 95. / 72 Read more »
Source: CBSNews - 🏆 87. / 68 Read more »
Source: bbchealth - 🏆 143. / 63 Read more »
Source: denverpost - 🏆 13. / 72 Read more »
Source: PennLive - 🏆 463. / 53 Read more »